Maven Capital in £3.9m boost for Crawford Scientific
ByGraham Huband
Private equity group Maven Capital Partners has completed a £3.9 million investment in Scottish scientific products and technical support services group Crawford Scientific.
The firm, which counts pharma giants GSK and AstraZeneca and oil major BP among its blue-chip client base, was founded in 1985 and has since grown to a £10m+ turnover concern.
Maven yesterday said its investment would allow Crawford to increase its service offering, develop new markets and consider strategic acquisition opportunities.
Maven Capital in £3.9m boost for Crawford Scientific